KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Accumulated Expenses (2018 - 2025)

Twist Bioscience (TWST) has disclosed Other Accumulated Expenses for 5 consecutive years, with $19.7 million as the latest value for Q3 2022.

  • On a quarterly basis, Other Accumulated Expenses rose 105.1% to $19.7 million in Q3 2022 year-over-year; TTM through Sep 2022 was $19.7 million, a 105.1% increase, with the full-year FY2022 number at $19.7 million, up 105.1% from a year prior.
  • Other Accumulated Expenses was $19.7 million for Q3 2022 at Twist Bioscience, up from $13.9 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $22.5 million in Q4 2019 to a low of $52000.0 in Q1 2020.
  • A 5-year average of $6.1 million and a median of $2.6 million in 2020 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: tumbled 94.18% in 2020, then skyrocketed 7713.46% in 2021.
  • Twist Bioscience's Other Accumulated Expenses stood at $1.1 million in 2018, then soared by 1996.92% to $22.5 million in 2019, then crashed by 85.31% to $3.3 million in 2020, then skyrocketed by 319.12% to $13.9 million in 2021, then soared by 42.44% to $19.7 million in 2022.
  • Per Business Quant, the three most recent readings for TWST's Other Accumulated Expenses are $19.7 million (Q3 2022), $13.9 million (Q4 2021), and $9.6 million (Q3 2021).